Cause and prevention of demyelination in a model multiple sclerosis lesion
Open Access
- 27 January 2016
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 79 (4), 591-604
- https://doi.org/10.1002/ana.24607
Abstract
Objective Demyelination is a cardinal feature of multiple sclerosis, but it remains unclear why new lesions form, and whether they can be prevented. Neuropathological evidence suggests that demyelination can occur in the relative absence of lymphocytes, and with distinctive characteristics suggestive of a tissue energy deficit. The objective was to examine an experimental model of the early multiple sclerosis lesion and identify pathogenic mechanisms and opportunities for therapy. Methods Demyelinating lesions were induced in the rat spinal dorsal column by microinjection of lipopolysaccharide, and examined immunohistochemically at different stages of development. The efficacy of treatment with inspired oxygen for 2 days following lesion induction was evaluated. Results Demyelinating lesions were not centered on the injection site, but rather formed 1 week later at the white–gray matter border, preferentially including the ventral dorsal column watershed. Lesion formation was preceded by a transient early period of hypoxia and increased production of superoxide and nitric oxide. Oligodendrocyte numbers decreased at the site shortly afterward, prior to demyelination. Lesions formed at a site of inherent susceptibility to hypoxia, as revealed by exposure of naive animals to a hypoxic environment. Notably, raising the inspired oxygen (80%, normobaric) during the hypoxic period significantly reduced or prevented the demyelination. Interpretation Demyelination characteristic of at least some early multiple sclerosis lesions can arise at a vascular watershed following activation of innate immune mechanisms that provoke hypoxia, and superoxide and nitric oxide formation, all of which can compromise cellular energy sufficiency. Demyelination can be reduced or eliminated by increasing inspired oxygen to alleviate the transient hypoxia. Ann Neurol 2016;79:591–604Funding Information
- Medical Research Council
- Multiple Sclerosis Society
- National Multiple Sclerosis Society
This publication has 53 references indexed in Scilit:
- The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion DevelopmentMultiple Sclerosis International, 2013
- Oligodendrocytes and the early multiple sclerosis lesionAnnals of Neurology, 2012
- Oligodendroglia metabolically support axons and contribute to neurodegenerationNature, 2012
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injuryBrain, 2012
- Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelinationActa Neuropathologica, 2010
- The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test–retest studyNeuroImage, 2010
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?Brain, 2007
- The Pathophysiology of Watershed Infarction in Internal Carotid Artery DiseaseStroke, 2005
- Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and GlutathioneNeuroscience & Biobehavioral Reviews, 1997